Liz Doolin, MSc

About Liz

Liz has over 25 years international experience in clinical and life sciences research. Liz has overseen clinical development programs for small molecules and biologics in various CNS disorders and in oncology. She joined Bionomics Limited (a fully owned subsidiary of Neuphoria Therapeutics) in 2008 to lead the clinical development program and regulatory strategy for their investigational drugs encompassing the design and execution of 20+ early and late-stage clinical studies.

In addition to her extensive clinical research and operations experience, Liz has a strong immunology and biochemistry research background, as well as biopharmaceutical development and manufacturing experience.